PetVivo Holdings, Inc.
General ticker "PETV" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $16.7M (TTM average)
PetVivo Holdings, Inc. follows the US Stock Market performance with the rate: 42.2%.
Estimated limits based on current volatility of 2.1%: low 1.10$, high 1.15$
Factors to consider:
- Total employees count: 20 (-20.0%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Nasdaq delisting risk, Product commercialization failure, Product liability, Labor/talent shortage/retention, Reputation and brand risks
- Current price 15.7% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [0.29$, 0.97$]
- 2026-03-31 to 2027-03-31 estimated range: [0.27$, 0.88$]
Financial Metrics affecting the PETV estimates:
- Positive: with PPE of -1.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -47.78 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: -14.38 < Investing cash flow per share per price, % of -5.06
- Positive: Industry inventory ratio change (median), % of -0.93 <= -0.15
- Positive: 41.86 < Shareholder equity ratio, % of 45.18 <= 63.39
- Positive: Inventory ratio change, % of -6.49 <= -0.75
- Positive: Interest expense per share per price, % of 3.23 <= 3.41
Short-term PETV quotes
Long-term PETV plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $0.92MM | $0.97MM | $1.13MM |
| Operating Expenses | $9.65MM | $11.59MM | $9.19MM |
| Operating Income | $-8.73MM | $-10.62MM | $-8.06MM |
| Non-Operating Income | $0.02MM | $-0.33MM | $-0.34MM |
| Interest Expense | $0.00MM | $0.00MM | $0.36MM |
| R&D Expense | $1.00MM | $1.27MM | $1.58MM |
| Income(Loss) | $-8.72MM | $-10.96MM | $-8.40MM |
| Profit(Loss)* | $-8.70MM | $-10.96MM | $-8.40MM |
| Stockholders Equity | $0.73MM | $0.69MM | $4.22MM |
| Inventory | $0.37MM | $0.39MM | $0.32MM |
| Assets | $2.44MM | $3.12MM | $9.34MM |
| Operating Cash Flow | $-6.79MM | $-7.42MM | $-5.32MM |
| Capital expenditure | $0.42MM | $0.31MM | $0.56MM |
| Investing Cash Flow | $-0.42MM | $-0.31MM | $-0.56MM |
| Financing Cash Flow | $1.59MM | $7.34MM | $6.03MM |
| Earnings Per Share** | $-0.85 | $-0.78 | $-0.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.